Next Article in Journal
Paralytic Shellfish Toxins and Ocean Warming: Bioaccumulation and Ecotoxicological Responses in Juvenile Gilthead Seabream (Sparus aurata)
Next Article in Special Issue
Immunogenicity Associated with Botulinum Toxin Treatment
Previous Article in Journal
The Activity of Isoquinoline Alkaloids and Extracts from Chelidonium majus against Pathogenic Bacteria and Candida sp.
Previous Article in Special Issue
Content/Potency Assessment of Botulinum Neurotoxin Type-A by Validated Liquid Chromatography Methods and Bioassays
Open AccessArticle

Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E

1
Foodborne Toxin Detection and Prevention Research Unit, Agricultural Research Service, United States Department of Agriculture, 800 Buchanan Street, Albany, CA 94710, USA
2
Produce Safety and Microbiology Research Unit, Agricultural Research Service, United States Department of Agriculture, 800 Buchanan Street, Albany, CA 94710, USA
*
Authors to whom correspondence should be addressed.
Toxins 2019, 11(7), 407; https://doi.org/10.3390/toxins11070407
Received: 29 May 2019 / Revised: 9 July 2019 / Accepted: 12 July 2019 / Published: 13 July 2019
(This article belongs to the Special Issue Characterization and Quantitative Analysis of Botulinum Neurotoxin)
Botulism is a devastating disease caused by botulinum neurotoxins (BoNTs) secreted primarily by Clostridium botulinum. Mouse bioassays without co-inoculation with antibodies are the standard method for the detection of BoNTs, but are not capable of distinguishing between the different serotypes (A–G). Most foodborne intoxications are caused by serotypes BoNT/A and BoNT/B. BoNT/E outbreaks are most often observed in northern coastal regions and are associated with eating contaminated marine animals and other fishery products. Sandwich enzyme-linked immunosorbent assays (ELISAs) were developed for the detection of BoNT/E3. Monoclonal antibodies (mAbs) were generated against BoNT/E3 by immunizing with recombinant peptide fragments of the light and heavy chains of BoNT/E3. In all, 12 mAbs where characterized for binding to both the recombinant peptides and holotoxin, as well as their performance in Western blots and sandwich ELISAs. The most sensitive sandwich assay, using different mAbs for capture and detection, exhibited a limit of detection of 0.2 ng/ml in standard buffer matrix and 10 ng/mL in fish product matrices. By employing two different mAbs for capture and detection, a more standardized sandwich assay was constructed. Development of sensitive and selective mAbs to BoNT/E would help in the initial screening of potential food contamination, speeding diagnosis and reducing use of laboratory animals. View Full-Text
Keywords: monoclonal antibodies; botulinum neurotoxin serotype E; BoNT/E; ELISA; immunoassay monoclonal antibodies; botulinum neurotoxin serotype E; BoNT/E; ELISA; immunoassay
Show Figures

Graphical abstract

MDPI and ACS Style

Bever, C.S.; Scotcher, M.; Cheng, L.W.; Hnasko, R.M.; Stanker, L.H. Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E. Toxins 2019, 11, 407. https://doi.org/10.3390/toxins11070407

AMA Style

Bever CS, Scotcher M, Cheng LW, Hnasko RM, Stanker LH. Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E. Toxins. 2019; 11(7):407. https://doi.org/10.3390/toxins11070407

Chicago/Turabian Style

Bever, Candace S.; Scotcher, Miles; Cheng, Luisa W.; Hnasko, Robert M.; Stanker, Larry H. 2019. "Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E" Toxins 11, no. 7: 407. https://doi.org/10.3390/toxins11070407

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop